139 related articles for article (PubMed ID: 24785530)
1. Genotyping of high-risk human papillomaviruses in p16/Ki-67-positive urothelial carcinoma cells: even a worm will turn.
Advenier AS; Casalegno JS; Mekki Y; Decaussin-Petrucci M; Mège-Lechevallier F; Ruffion A; Piaton E
Cytopathology; 2015 Apr; 26(2):106-13. PubMed ID: 24785530
[TBL] [Abstract][Full Text] [Related]
2. p16(INK4a) overexpression is not linked to oncogenic human papillomaviruses in patients with high-grade urothelial cancer cells.
Piaton E; Casalegno JS; Advenier AS; Decaussin-Petrucci M; Mege-Lechevallier F; Ruffion A; Mekki Y
Cancer Cytopathol; 2014 Oct; 122(10):760-9. PubMed ID: 25069600
[TBL] [Abstract][Full Text] [Related]
3. p16(INK4a) /Ki-67 dual labelling as a marker for the presence of high-grade cancer cells or disease progression in urinary cytopathology.
Piaton E; Advenier AS; Carré C; Decaussin-Petrucci M; Mege-Lechevallier F; Ruffion A
Cytopathology; 2013 Oct; 24(5):327-34. PubMed ID: 23003335
[TBL] [Abstract][Full Text] [Related]
4. High-risk HPV infection and CIN grade correlates to the expression of c-myc, CD4+, FHIT, E-cadherin, Ki-67, and p16INK4a.
Samir R; Asplund A; Tot T; Pekar G; Hellberg D
J Low Genit Tract Dis; 2011 Oct; 15(4):280-6. PubMed ID: 21558960
[TBL] [Abstract][Full Text] [Related]
5. [P16(INK4alpha)/Ki-67 immunocytochemical dual staining for detection of cervical lesions associated to papillomavirus infection].
Toro de Méndez M; Ferrández Izquierdo A; Llombart-Bosch A
Invest Clin; 2014 Sep; 55(3):238-48. PubMed ID: 25272523
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of combining testing for p16 protein and human papillomavirus (HPV) in cervical carcinoma screening.
Ekalaksananan T; Pientong C; Sriamporn S; Kongyingyoes B; Pengsa P; Kleebkaow P; Kritpetcharat O; Parkin DM
Gynecol Oncol; 2006 Oct; 103(1):62-6. PubMed ID: 16494930
[TBL] [Abstract][Full Text] [Related]
7. p16 INK4a overexpression and p16/Ki-67 dual labeling versus conventional urinary cytology in the evaluation of urothelial carcinoma.
Piaton E; Carré C; Advenier AS; Decaussin-Petrucci M; Mège-Lechevallier F; Lantier P; Granier G; Ruffion A
Cancer Cytopathol; 2014 Mar; 122(3):211-20. PubMed ID: 24302621
[TBL] [Abstract][Full Text] [Related]
8. HPV16 genotype, p16/Ki-67 dual staining and koilocytic morphology as potential predictors of the clinical outcome for cervical low-grade squamous intraepithelial lesions.
Vrdoljak-Mozetič D; Krašević M; Verša Ostojić D; Štemberger-Papić S; Rubeša-Mihaljević R; Bubonja-Šonje M
Cytopathology; 2015 Feb; 26(1):10-8. PubMed ID: 24261348
[TBL] [Abstract][Full Text] [Related]
9. Increased Ki-67 proliferative index and absence of P16INK4 in CIN-HPV related pathogenic pathways different from cervical squamous intraepithelial lesion.
Kuo KT; Chang HC; Hsiao CH; Lin MC
Br J Ophthalmol; 2006 Jul; 90(7):894-9. PubMed ID: 16540490
[TBL] [Abstract][Full Text] [Related]
10. Carcinoma of the Uterine Cervix Involving the Genitourinary Tract: A Potential Diagnostic Dilemma.
Schwartz LE; Khani F; Bishop JA; Vang R; Epstein JI
Am J Surg Pathol; 2016 Jan; 40(1):27-35. PubMed ID: 26426382
[TBL] [Abstract][Full Text] [Related]
11. P16/CDKN2A and Ki-67 enhance the detection of anal intraepithelial neoplasia and condyloma and correlate with human papillomavirus detection by polymerase chain reaction.
Pirog EC; Quint KD; Yantiss RK
Am J Surg Pathol; 2010 Oct; 34(10):1449-55. PubMed ID: 20871219
[TBL] [Abstract][Full Text] [Related]
12. Anal intraepithelial neoplasia: correlation of grade with p16INK4a immunohistochemistry and HPV in situ hybridization.
Bernard JE; Butler MO; Sandweiss L; Weidner N
Appl Immunohistochem Mol Morphol; 2008 May; 16(3):215-20. PubMed ID: 18301250
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
[TBL] [Abstract][Full Text] [Related]
14. Combination of p16(INK4a) /Ki67 immunocytology and HPV polymerase chain reaction for the noninvasive analysis of HPV involvement in head and neck cancer.
Linxweiler M; Bochen F; Wemmert S; Lerner C; Hasenfus A; Bohle RM; Al-Kadah B; Takacs ZF; Smola S; Schick B
Cancer Cytopathol; 2015 Apr; 123(4):219-29. PubMed ID: 25557267
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical staining of p16INK4a protein from conventional Pap test and its association with human papillomavirus infection.
Pientong C; Ekalaksananan T; Kongyingyoes B; Kritpetcharat O; Swadpanich U; Pengsa P; Yuenyao P
Diagn Cytopathol; 2004 Oct; 31(4):235-42. PubMed ID: 15452898
[TBL] [Abstract][Full Text] [Related]
16. Utility of P16 expression and Ki-67 proliferation index in ASCUS and ASC-H pap tests.
Toll AD; Kelly D; Maleki Z
Diagn Cytopathol; 2014 Jul; 42(7):576-81. PubMed ID: 24288264
[TBL] [Abstract][Full Text] [Related]
17. P16 and Ki67 immunostaining is a useful adjunct in the assessment of biopsies for HPV-associated anal intraepithelial neoplasia.
Walts AE; Lechago J; Bose S
Am J Surg Pathol; 2006 Jul; 30(7):795-801. PubMed ID: 16819320
[TBL] [Abstract][Full Text] [Related]
18. P16INK4a expression, human papillomavirus, and survival in head and neck cancer.
Smith EM; Wang D; Kim Y; Rubenstein LM; Lee JH; Haugen TH; Turek LP
Oral Oncol; 2008 Feb; 44(2):133-42. PubMed ID: 17360226
[TBL] [Abstract][Full Text] [Related]
19. p16/Ki-67 dual labeling and urinary cytology results according to the New Paris System for Reporting Urinary Cytology: Impact of extended follow-up.
Piaton E; Advenier AS; Carré C; Decaussin-Petrucci M; Mège-Lechevallier F; Hutin K; Nennig C; Colombel M; Ruffion A
Cancer Cytopathol; 2017 Jul; 125(7):552-562. PubMed ID: 28371465
[TBL] [Abstract][Full Text] [Related]
20. Combining routine morphology, p16(INK4a) immunohistochemistry, and in situ hybridization for the detection of human papillomavirus infection in penile carcinomas: a tissue microarray study using classifier performance analyses.
Chaux A; Cubilla AL; Haffner MC; Lecksell KL; Sharma R; Burnett AL; Netto GJ
Urol Oncol; 2014 Feb; 32(2):171-7. PubMed ID: 23499169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]